Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Xiuying Liu et al.|Nature Cancer|2023Cited by 219
Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB PathwayQiu Li, Zhihui Hao|Molecules|2018Cited by 41
NADPH Oxidases‐Inspired Reactive Oxygen Biocatalysts with Electron‐Rich Pt Sites to Potently Amplify Immune Checkpoint Blockade TherapyChuyi Han, Chong Cheng, Sutong Xiao et al.|Advanced Materials|2024Cited by 21
Enzyme-reaction-system inspired nanobiocatalysts for bioadaptively eradicating primary and metastatic cancersSutong Xiao, Chong Cheng, Chuyi Han et al.|Cell Biomaterials|2025Cited by 2
NADPH Oxidases‐Inspired Reactive Oxygen Biocatalysts with Electron‐Rich Pt Sites to Potently Amplify Immune Checkpoint Blockade Therapy (Adv. Mater. 3/2025)Chuyi Han, Chong Cheng, Sutong Xiao et al.|Advanced Materials|2025Cited by 1